MDimune and SensoryCure announce a collaboration to develop therapeutics for hearing loss
MDimune, Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), enters into an MOU with SensoryCure to
Stay updated with breaking news from Shingyu Bae. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MDimune, Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), enters into an MOU with SensoryCure to
MDimune Inc., a biotech company developing BioDrone® platform technology based on cell-derived vesicles (CDVs), has announced the finalists of the research-funded project; the 2021 BioDrone® Award.
NeoCura Bio-Medical Technology Co., Ltd, a leading AI-enabled RNA precision medicine company based on research, development and MDimune Inc., a leading extracellular vesicle (EV)-based drug delivery platform company, has announced the signing of collaboration focused on mRNA delivery for oncological therapeutics.